ATC code - L01EG02
PolandEverolimus
-
Form: tablets
Active substance Dosage everolimus 2.5 mg ATC code: L01EG02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets
Active substance Dosage everolimus 5 mg ATC code: L01EG02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets
Active substance Dosage everolimus 10 mg ATC code: L01EG02
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Form: tablets
Active substance Dosage everolimus 5 mg ATC code: L01EG02
Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd., STADA Arzneimittel AG, STADA Arzneimittel GmbH
-
Form: tablets
Active substance Dosage everolimus 10 mg ATC code: L01EG02
Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd., STADA Arzneimittel AG, STADA Arzneimittel GmbH
-
Form: tablets
Active substance Dosage everolimus 2.5 mg ATC code: L01EG02
Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.
-
Form: tablets
Active substance Dosage everolimus 5 mg ATC code: L01EG02
Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.
-
Form: tablets
Active substance Dosage everolimus 10 mg ATC code: L01EG02
Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.